Patents Assigned to Syntello Vaccine Development KB
  • Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
    Patent number: 5840313
    Abstract: Novel peptides are disclosed which correspond to epitopes of the HIV-1 gp120 protein. These antigenic peptides induce antibody-dependent cellular cytotoxicity against HIV, and thus are useful in immunization against HIV infection and induction of a heightened immune response to HIV.
    Type: Grant
    Filed: June 20, 1995
    Date of Patent: November 24, 1998
    Assignee: Syntello Vaccine Development KB
    Inventors: Anders Vahlne, Bo Syennerholm, Lars Rymo, Stig Jeansson, Peter Horal
  • Peptides for induction of neutralizing antibodies against human immunodeficiency virus
    Patent number: 5589175
    Abstract: In accordance with the present invention, novel peptides corresponding to epitopes of human immunodeficiency virus-1 gp120 protein and analogues and homologs thereof are provided. These peptides can be utilized alone or in combination, uncoupled or coupled to other molecules or substrates. The peptides are useful in immunization against human immunodeficiency virus infection and in production of polyclonal and monoclonal antibodies.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: December 31, 1996
    Assignee: Syntello Vaccine Development KB
    Inventors: Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal
  • Peptides for use in induction of T cell activation against HIV-1
    Patent number: 5346989
    Abstract: Peptides corresponding to regions of the human immunodeficiency virus protein gp-120 are provided for eliciting T-cell activation.
    Type: Grant
    Filed: September 13, 1993
    Date of Patent: September 13, 1994
    Assignee: Syntello Vaccine Development KB
    Inventors: Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal, Cecil Czerkinsky, Jan Holmgren